You are here
Management of Patients under Radiotherapy: oral mucositis
By Joel Epstein, recorded at TAO (Transatlantic Oncology meeting), Nov 20-21, 2014, Paris
The true incidence of oral mucositis is underestimated, as most patients only report it when asked directly. Joel Epstein discusses why mucositis matters in the treatment of a potentially fatal disease. Mucositis is a common and debilitating condition which causes pain, affects oral function and leads to acute and/or chronic complications such as stomatitis, alterations in taste perception and saliva production, tissue necrosis, caries, etc. This can result, for example, in dehydration, weight loss or an increased use of analgetics. As a result, it may be necessary to reduce or discontinue the cancer treatment or hospitalise the patient, which has a major impact on the completion of cancer therapy, affects the patient’s quality of life and leads to increased costs.
Joel Epstein, City of Hope Cancer Center, San Francisco, USA